首页> 外文期刊>Journal of Clinical Epidemiology >The generalizability of observational data to elderly patients was dependent on the research question in a systematic review.
【24h】

The generalizability of observational data to elderly patients was dependent on the research question in a systematic review.

机译:观察数据对老年患者的一般性取决于系统评价中的研究问题。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND OBJECTIVE: Despite the increasing use of data derived from randomized controlled trials (RCTs) to perform observational studies, little is known about the validity of this approach. We compared inferences from studies that were performed using Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) RCT data with those derived from studies using data from the population-based Cooperative Cardiovascular Project (CCP). METHODS: We performed a systematic review. Articles were included if similar study questions were addressed by at least one manuscript that used GUSTO data and one that used CCP data. RESULTS: GUSTO findings were disparate from CCP data regarding absolute rates of specific process or outcome measures, such as thrombolysis-associated intracranial hemorrhage (ICH) (0.65% versus 1.43%, respectively), atrial fibrillation (10% versus 21%, respectively), or use of beta-blockers (58% versus 37%, respectively). However, many important relations noted in GUSTO were corroborated by studies using CCP data. Both data sets identified similar predictors of ICH and presentation delay. The degree of variability in beta-blocker use (across geographic region) and angiography use (between genders) was remarkably similar when studied using CCP or GUSTO data. CONCLUSION: Inferences derived from GUSTO about treatment variations and risk factors for outcomes were generalizable to community patients.
机译:背景与目的:尽管越来越多地使用来自随机对照试验(RCT)的数据进行观察性研究,但对该方法的有效性知之甚少。我们比较了使用链激酶和t-PA对冠状动脉阻塞(GUSTO)RCT数据的全球利用进行的研究得出的推论,以及使用基于人群的合作性心血管计划(CCP)的数据得出的推论。方法:我们进行了系统的审查。如果至少有一份使用GUSTO数据的手稿和一份使用CCP数据的手稿解决了类似的研究问题,则包括文章。结果:关于特定过程或预后指标的绝对率,GUSTO结果与CCP数据不同,例如溶栓相关的颅内出血(ICH)(分别为0.65%对1.43%),房颤(分别为10%对21%)或使用β受体阻滞剂(分别为58%和37%)。但是,使用CCP数据进行的研究证实了GUSTO中提到的许多重要关系。这两个数据集都确定了ICH和表现延迟的相似预测因子。使用CCP或GUSTO数据进行研究时,β受体阻滞剂的使用(在整个地理区域)和血管造影术的使用(在性别之间)的变化程度非常相似。结论:从GUSTO得出的关于治疗变异和预后风险因素的推论可推广到社区患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号